Nabriva Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Jun '23 Jun 30, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018
Cash & Equivalents	2.18	12.41	47.66	41.36	86.02	102
Short-Term Investments	-	-	0.02	0.02	0.18	0.23
Cash & Short-Term Investments	2.18	12.41	47.68	41.38	86.19	102.23
Cash Growth	-89.11%	-73.96%	15.23%	-52.00%	-15.68%	17.67%
Accounts Receivable	4.44	5.95	12.21	3.79	1.53	4.26
Other Receivables	-	0.79	0.54	0.12	1.21	1.11
Receivables	4.44	6.74	12.75	3.91	2.74	5.37
Inventory	-	9.68	14.51	5.82	0.68	-
Prepaid Expenses	3.26	2.15	5.16	5.88	1.16	1.15
Restricted Cash	0.07	0.12	0.18	0.23	0.39	-
Total Current Assets	9.95	31.1	80.27	57.22	91.17	108.75
Property, Plant & Equipment	0.25	0.28	0.23	0.77	2.47	1.14
Other Intangible Assets	0	0	0.03	0.08	0.09	0.1
Other Long-Term Assets	0.38	0.38	0.38	0.37	0.38	0.43
Total Assets	10.58	31.77	80.91	58.44	94.11	110.42
Accounts Payable	14.03	5.43	4.37	2.89	4.67	3.3
Accrued Expenses	7.9	7.15	9.45	5.89	8.63	12.86
Current Portion of Long-Term Debt	0.2	4.83	3.77	2.04	-	-
Current Unearned Revenue	-	-	0.37	0.75	-	-
Other Current Liabilities	4.08	10.19	4.38	6.96	3.34	1.65
Total Current Liabilities	26.2	27.61	22.34	18.52	16.64	17.81
Long-Term Debt	0.34	0.39	4.27	5.69	34.5	23.72
Other Long-Term Liabilities	0.35	0.48	0.95	1.09	1.7	0.26
Total Liabilities	26.9	28.47	27.56	25.3	52.84	41.79
Common Stock	0.03	0.03	0.02	0.21	0.1	0.67
Additional Paid-In Capital	657.24	656.1	648.98	579.12	517.89	461.91
Retained Earnings	-673.62	-652.86	-595.68	-546.23	-476.74	-393.98
Comprehensive Income & Other	0.03	0.03	0.03	0.03	0.03	0.03
Shareholders' Equity	-16.32	3.29	53.35	33.14	41.27	68.63
Total Liabilities & Equity	10.58	31.77	80.91	58.44	94.11	110.42
Total Debt	0.54	5.22	8.03	7.73	34.5	23.72
Net Cash (Debt)	1.64	7.19	39.65	33.65	51.69	78.51
Net Cash Growth	-87.28%	-81.86%	17.82%	-34.91%	-34.16%	-9.39%
Net Cash Per Share	0.53	2.68	22.86	65.49	174.17	386.40
Filing Date Shares Outstanding	3.23	3.2	2.42	1	0.38	0.28
Total Common Shares Outstanding	3.23	3.2	2.27	0.84	0.38	0.27
Working Capital	-16.25	3.5	57.93	38.69	74.53	90.95
Book Value Per Share	-5.05	1.03	23.52	39.30	109.14	256.01
Tangible Book Value	-16.32	3.29	53.32	33.06	41.18	68.53
Tangible Book Value Per Share	-5.05	1.03	23.50	39.20	108.90	255.64
Machinery	-	4.8	4.59	4.67	4.6	4.6

Updated Oct 19, 2023. Source: S&P Global Market Intelligence. Standard template. Financial Sources.